PGHH - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 3.0
✅ Positive
Procter & Gamble Hygiene & Health Care Ltd. exhibits strong profitability with a high ROE and ROCE, indicating efficient capital utilization. The company’s dividend yield of 2.68% provides an attractive income stream for investors. A market rally could potentially provide support to the stock price.
⚠️ Limitation
Recent financial results show a significant decline in profit margins (-34.2%) and earnings per share, alongside a contraction in the overall industry PE ratio (39.5). The substantial decrease in DII holding suggests waning investor interest.
📉 Company Negative News
Profit slumped 34% due to contracting margins, leading to a 52-week low and a stock-specific sell-off according to marketmojo.com.
📈 Company Positive News
None found.
🏭 Industry
The hygiene & health care industry is generally considered defensive and resilient, driven by consumer staples demand. However, competitive pressures from established brands and emerging players are impacting margins, as evidenced by the industry’s elevated P/E ratio.
🧾 Conclusion
Considering the current undervaluation indicated by a P/E of 35.3 and a PEG ratio of 2.51, an entry zone between 8,400 ₹ and 8,600 ₹ presents an attractive opportunity. Long-term holding guidance suggests monitoring margins closely and assessing future growth potential within the consumer staples sector; a recovery in profitability would justify continued investment. The company’s solid fundamentals remain compelling despite recent challenges.